Joseph Sarah, Pike Sarah, Peng Chen-Ching, Brown Brianne, Xu Liya, Berry Jesse L, Chévez-Barrios Patricia, Hubbard G Baker, Grossniklaus Hans E
Department of Ophthalmology, Emory University School of Medicine, Los Angeles, CA, USA.
Children's Hospital Los Angeles and the USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Ocul Oncol Pathol. 2024 Apr;10(1):15-24. doi: 10.1159/000533311. Epub 2023 Aug 25.
The objective of this study was to report the clinicopathologic features of three cases of -amplified retinoblastoma identified genetically by aqueous humor sampling.
Whole-genome sequencing was performed using isolated cell-free DNA (cfDNA) from aqueous humor of 3 retinoblastoma patients. We analyzed genomic copy number and mutational alterations, histologic and pathologic features, and clinical data.
The most common genetic alteration identified in these three retinoblastoma cases was a focal amplification on 2p. All tumors showed an early age of diagnosis with a median of 9 months. The tumor histopathologic features included neovascularization and subretinal seeding in case 1, diffuse nature with choroidal and prelaminar optic nerve invasion in case 2, and complete vitreous seeding in case 3. Case 1 expressed RB protein and had no mutation, case 2 did not express RB protein and had an mutation, and case 3 did not express RB protein and likely had an epigenetic effect on RB expression.
Our report shows 3 cases of unilateral retinoblastomas diagnosed in patients ranging from 4 months to 18 months old. Genomic analysis from AH cfDNA revealed amplification with intact RB protein staining in case 1 and lack of RB staining in cases 2 and 3. mutational analysis in the AH confirmed a pathogenic variant in case 2. Clinical pathology showed features requiring aggressive treatment, specifically enucleation.
-amplified retinoblastomas demonstrate unique pathogenesis and aggressive behavior, regardless if is a primary or secondary driver of disease. Genomic analysis from aqueous humor may be useful when deciding to enucleate as opposed to treating conservatively. Focal amplification on 2p might be relevant for tumor growth in this subset of the retinoblastoma population in terms of targeted therapeutics.
本研究的目的是报告通过房水采样基因鉴定出的三例MYCN扩增的视网膜母细胞瘤的临床病理特征。
对3例视网膜母细胞瘤患者房水中分离出的游离细胞DNA(cfDNA)进行全基因组测序。我们分析了基因组拷贝数和突变改变、组织学和病理学特征以及临床数据。
在这三例视网膜母细胞瘤病例中鉴定出的最常见基因改变是2p上的局灶性MYCN扩增。所有肿瘤诊断时年龄均较小,中位年龄为9个月。肿瘤组织病理学特征包括病例1中的新生血管形成和视网膜下播散,病例2中的弥漫性特征伴脉络膜和视神经板前浸润,病例3中的完全玻璃体播散。病例1表达RB蛋白且无MYCN突变,病例2不表达RB蛋白且有MYCN突变,病例3不表达RB蛋白且可能对RB表达有表观遗传效应。
我们的报告显示3例单侧视网膜母细胞瘤,患者年龄在4个月至18个月之间。房水cfDNA的基因组分析显示病例1中MYCN扩增且RB蛋白染色完整,病例2和3中缺乏RB染色。房水中的MYCN突变分析证实病例2存在致病变异。临床病理学显示需要积极治疗的特征,特别是眼球摘除术。
MYCN扩增的视网膜母细胞瘤表现出独特的发病机制和侵袭性,无论MYCN是疾病的主要还是次要驱动因素。与保守治疗相比,房水的基因组分析在决定是否进行眼球摘除术时可能有用。2p上的局灶性MYCN扩增在视网膜母细胞瘤人群的这一亚组中对于肿瘤生长可能与靶向治疗相关。